A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report.

doi:10.1097/01.aids.0000180113.18938.51

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report.

AIDS (London, England) - 12 Aug 2005

Kolber Michael A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Antiretroviral Therapy, Highly Active
Share to Benzoxazines
Share to Contraindications

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Drug Resistance, Multiple, Viral

Share to Oxazines

Share to Salvage Therapy

Source

Open in PubMed

Identifiers

PMID: 16052097
DOI: 10.1097/01.aids.0000180113.18938.51

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report.PMID 16052097Read ↗

Efavirenz – Still First-line King?Semantic proximity Read ↗

[Emergence of entecavir genotypic resistance in a nucleoside naive chronic hepatitis B patient who had been treated for nearly five years: a case report].Semantic proximity Read ↗

Efavirenz: resistance and cross-resistance.Semantic proximity Read ↗

Salvage therapy for patients failing their current antiretroviral regimen.Semantic proximity Read ↗

Efavirenz.Semantic proximity Read ↗

AZT or tenofovir for patients with the K65R mutation?Semantic proximity Read ↗

A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.Semantic proximity Read ↗

[Resistance to nucleoside reverse transcriptase inhibitors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.